[Retracted] Antitumor activity of NRC‑AN‑019 in a pre‑clinical breast cancer model.

Saved in:
Bibliographic Details
Title: [Retracted] Antitumor activity of NRC‑AN‑019 in a pre‑clinical breast cancer model.
Authors: Gondi CS; Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA., Gorantla B; Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA., Rao AKSB; NATCO Pharma Limited, Telangana 509228, India., Amala K; NATCO Pharma Limited, Telangana 509228, India., Naidu MUR; Nizam's Institute of Medical Sciences, Telangana 500082, India., Jogi KV; NATCO Pharma Limited, Telangana 509228, India., Ramana GV; NATCO Pharma Limited, Telangana 509228, India., Myneni PC; NATCO Pharma Limited, Telangana 509228, India., Junnarkar A; NATCO Pharma Limited, Telangana 509228, India., Rao JS; Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
Source: International journal of oncology [Int J Oncol] 2026 Jun; Vol. 68 (6). Date of Electronic Publication: 2026 Apr 03.
Publication Type: Journal Article; Retraction Notice
Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1791-2423
DOI:10.3892/ijo.2026.5879